The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.
Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
US panel of experts on Thursday voted to recommend emergency approval of Moderna's Covid-19 vaccine, paving the way for six million doses to start shipping as soon as this weekend.
Moderna's vaccine is safe and effective for preventing Covid-19, US regulators said, clearing the way for a second shot to quickly gain emergency authorization and add to the country's sprawling immunization effort.
United States health authorities, shipping services and hospitals stood ready on Friday to immediately launch a mass-inoculation campaign of unparalleled dimension, as federal regulators granted emergency approval to the first COVID-19 vaccine in the United States.
A panel of outside advisers to the US Food and Drug Administration on Thursday (Dec 10) voted overwhelmingly to endorse emergency use of Pfizer Inc's coronavirus vaccine, paving the way for the agency to authorize the shot for a nation that has lost more than 285,000 lives to Covid-19.
The United States Center for Disease Control and Prevention and the Food and Drug Administration are quickly moving to determine the source of the fungal infection causing a rare form of meningitis that has killed seven people in nine states in the last few weeks, as the producer of the steroid injection apparently carrying the infection recalled all of its products.